Clinical Genomics

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 - PubMed | National Institutes of Health | 9/26/2020

… Primary Immunodeficiencies Group, University of Antioquia UdeA, Medellin, Colombia. School of Microbiology, University of Antioquia UdeA, Medellin, Colombia. Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA. NIAID Clinical Genomics Program, National Institutes of Health, Bethesda, MD, USA. Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Hôpital Saint-Louis, 75010 Paris, France. Laboratory of Genomes & Cell Biology of Disease, INSERM U944, CNRS …

Treating medical data as a durable asset | Stanford | 9/14/2020

… and countries. In reality, the access to and usability of medical data—as represented by the new field of medical data sciences—progresses slowly. These current limitations substantially affect the field of population and clinical genomics , which relies on the quality of data and on access to large numbers of individuals. In fact, genome analysis alone has limited value, but these data can be linked to electronic medical record (EMR …

Follow Clinical Genomics:    

WorkCare Provides COVID-19 Diagnostic Saliva Test for Workplace and Home Use | Business Wire | 9/10/2020

… polymerase chain reaction (PCR) molecular test methodology to detect unique genetic markers in saliva that are specific to the SARS-CoV-2 virus that causes COVID-19. A study performed at the Rutgers University Clinical Genomics Laboratory found the 1Health.io saliva test has greater than 99 percent sensitivity and specificity based on available data. Only 2 percent of results were inconclusive; the remainder were positive or negative. In addition to …

cg 12.1.6 | 9/4/2020

cg cg stands for Clinical Genomics ; a clinical sequencing platform under SciLifeLab This is our main package for interacting with data and samples that flow through our pipeline. We rely on a set of specialized “apps” to deal with a lot of complexity like: Trailblazer : Python wrapper around [MIP][mip], a rare disease genomics pipeline Housekeeper : storage, retrieval, and archival of files Genotype : managing genotypes for detecting sample mix-ups …

Sherlock Biosciences Announces Clinical Data from Dartmouth-Hitchcock Health’s Pilot Study of Sherlock™ CRISPR SARS-CoV-2 Kit | Business Wire | 9/2/2020

… Hitchcock’s lab-based polymerase chain reaction (PCR) test method. “We have been encouraged by results from the pilot study of Sherlock’s CRISPR-based test,” said Wahab Khan, Ph.D., Assistant Director of the Laboratory for Clinical Genomics and Advanced Technology at Dartmouth-Hitchcock. “At a time when COVID-19 clinical diagnosis is in high demand – and often with limited resources – this approach highlights the value of mature, new technologies to provide …

Evaluation of molecular inversion probe versus TruSeq® custom methods for targeted next-generation sequencing | 9/2/2020

… Roles Resources, Writing – review & editing Affiliation Neuroalgology Units, Fondazione IRCCS Istituto Neurologico “Carlo Besta” Milan, Milan, Italy ⨯ Hubert J. M. Smeets, Roles Conceptualization, Supervision, Writing – review & editing Affiliations Department of Genetics and Cell Biology, Clinical Genomics Unit, Maastricht University, Maastricht, The Netherlands, MHeNs school of Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands ⨯ Filippo Martinelli Boneschi, Roles Conceptualization, Funding acquisition, Writing – review & editing Affiliation Laboratory of Human Genetics of …

Sherlock Biosciences Announces Clinical Data from Dartmouth-Hitchcock Health’s Pilot Study of Sherlock™ CRISPR SARS-CoV-2 Kit | BioSpace | 9/1/2020

… Hitchcock’s lab-based polymerase chain reaction (PCR) test method. “We have been encouraged by results from the pilot study of Sherlock’s CRISPR-based test,” said Wahab Khan, Ph.D., Assistant Director of the Laboratory for Clinical Genomics and Advanced Technology at Dartmouth-Hitchcock. “At a time when COVID-19 clinical diagnosis is in high demand – and often with limited resources – this approach highlights the value of mature, new technologies to provide …

The Immuno-Oncology Diagnostics Market 2019-2030 - Focus on Checkpoint Assay, Cytokine Assay, Genome Germline, Genome Tumour, Tumour Micro Environment, and Other Types | PR Newswire | 9/1/2020

… Beckman Coulter Becton Dickinson Bioarray Genetics BioCartis Biocept Biodesix Inc. BioFluidica BioGenex bioMrieux Bio-Rad Bio-Techne Bristol- Myers Squibb Cancer Genetics Caris Molecular Diagnostics CellMax Life Charles River Chronix Biomedical Circulogene Clearbridge BioMedics Clinical Genomics Cynvenio Cytolumina Technologies Corp. CytoTrack Dako (Agilent) Diagnologix LLC Epic Sciences Exosome Diagnostics Fluidigm Corp Fluxion Biosciences Foundation Medicine Freenome Genomic Health GenomOncology GRAIL Guardant Health HalioDx Horizon Discovery HTG Molecular Diagnostics iCellate Illumina …

Global Genetic Testing Industry Outlook to 2023 with Market Shares by Key Players | PR Newswire | 8/28/2020

… Bioarray Genetics Biocept, Inc. Biodesix Inc. BioFluidica BioGenex Biolidics Ltd. bioMrieux Diagnostics Bioneer Corporation Bio-Rad Laboratories, Inc. Bio-Techne Cancer Genetics Caris Molecular Diagnostics CellMax Life Centogene Cepheid (now Danaher) Chronix Biomedical Circulogene Clinical Genomics Complete Genomics, Inc. - A BGI Company Cynvenio Dante Labs Datar Cancer Genetics Limited Diasorin S.p.A. Epic Sciences Epigenomics AG Eurofins Scientific Excellerate Bioscience Exosome Diagnostics Fabric Genomics Fluidigm Corp. Foundation Medicine Freenome FUJIFILM Wako …

Global In-Vitro Colorectal Cancer Screening Tests Market Growth (Status and Outlook) 2020-2025 | 8/26/2020

… also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. - Alere(Abbott) - Clinical Genomics Pty Ltd (Quest Diagnostics) - R-Biopharm - Sysmex In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole …

Global Next Generation Cancer Diagnostics Industry to 2025 | PR Newswire | 8/26/2020

… Biotheranostics Inc. Bluestar Genomics Inc. Cancer Genetics Inc. Caris Life Sciences Castle Biosciences Inc. CC Diagnostics Bv Celcuity Inc. Cell Microsystems Inc. Cellmax Life Cellular Analytics Celsee Diagnostics Chip Diagnostics Chronix Biomedical Circulogene Theranostics Clinical Genomics Technologies Codiak Biosciences Danaher Corp. Decipher Biosciences Dermtech Diacarta Inc. Dnalytics Epic Sciences Inc. Epigenomics Ag Exact Sciences Corp. Fluxion Biosciences Inc. Freenome Inc. Fulgent Genetics Inc. Genecentric Therapeutics Genedx Inc. Geneoscopy Llc Genera …

Kanteron Platform now available in Microsoft Azure Marketplace and AppSource | 8/26/2020

… Medicine Platform: Despite the potential of precision medicine, inefficient data sharing processes compromise patient care globally. Kanteron Systems leverages cutting-edge technology to connect and automate the integration of radiology medical imaging, digital pathology, clinical genomics , pharmacogenomics, and clinical data efficiently leading to enhanced care coordination and patient outcomes. Kanteron’s innovative platform provides industry-leading precision medicine at the point of care (POC). It addresses disparate complex cases, like cancer …

Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics | Globe Newswire | 8/24/2020

… cytogeneticists, genetic counselors, laboratory operations and billing experts, clinical commercialization experts, and payor contracts The addition of Lineagen gives Bionano a unique and powerful combination of centralized and decentralized solutions for genomics research and clinical genomics to help support revenue growth Bionano’s Saphyr system for comprehensive structural variation detection, together with Lineagen’s expertise in development, commercialization and reimbursement of LDTs through CLIA-certified services, provides the key ingredients to accelerate …

Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics - GuruFocus.com | 8/24/2020

… cytogeneticists, genetic counselors, laboratory operations and billing experts, clinical commercialization experts, and payor contracts The addition of Lineagen gives Bionano a unique and powerful combination of centralized and decentralized solutions for genomics research and clinical genomics to help support revenue growth Bionano’s Saphyr system for comprehensive structural variation detection, together with Lineagen’s expertise in development, commercialization and reimbursement of LDTs through CLIA-certified services, provides the key ingredients to accelerate …

Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics | 8/24/2020

… cytogeneticists, genetic counselors, laboratory operations and billing experts, clinical commercialization experts, and payor contracts The addition of Lineagen gives Bionano a unique and powerful combination of centralized and decentralized solutions for genomics research and clinical genomics to help support revenue growth Bionano’s Saphyr system for comprehensive structural variation detection, together with Lineagen’s expertise in development, commercialization and reimbursement of LDTs through CLIA-certified services, provides the key ingredients to accelerate …

Global Liquid Biopsy Markets By Cancer Type, By Diagnosis, Monitoring & Recurrence Testing to 2023 - ResearchAndMarkets.com | Business Wire | 8/21/2020

… 2.8.39 Trovagene 2.8.40 Freenome 2.8.41 Personal Genome Diagnostics 2.8.42 miR Scientific 2.8.43 MDx Health 2.8.44 Bioarray Genetics 2.8.45 Bio-Techne 2.8.46 Oncocyte 2.8.47 Circulogene 2.8.48 Incell Dx 2.8.49 Integrated Diagnostics 2.8.50 Bio Cartis 2.8.51 Clinical Genomics 2.8.52 OncoDNA 2.8.53 Biodesix Inc. 2.8.54 CellMax Life 3. Market Trends 3.1 Factors Driving Growth 3.1.1 Non Invasive Game Changer 3.1.2 Lower Cost 3.1.3 Greater Accuracy 3.1.4 Wide Range of Potential Uses 3.1.5 Aging …

Dartmouth-Hitchcock research into presence of COVID-19 in wastewater could offer clues about virus clusters | 8/20/2020

… project team for D-H are Clinical Chemist Jacqueline Hubbard, PhD, and Medical Microbiologist Isabella Martin, MD, along with Project coordinator Gregory Tsongalis, PhD, vice chair for Research and director of the Laboratory for Clinical Genomics and Advanced Technology in the Department of Pathology and Laboratory Medicine at D-H. The project name, RECOVER, stands for RE gional CO VID-19 V irus E valuation in R ecrement. “The idea …

Which skills do you need to teach a robot in a genomics lab? | 8/20/2020

How does a Hamilton automation specialist fit into a genomics lab? Genuity Science’s George Penman explains. Genuity Science, the clinical genomics research company, is currently hiring for a Hamilton automation specialist role. To learn more about the position and the kinds of skills Genuity is looking for, I spoke to one of its senior scientists, George Penman. His responsibilities include managing and implementing new next-generation sequencing processes in the …

Using the COVID-19 saliva-based test | 8/19/2020

… Food and Drug Administration (FDA) has granted the test an emergency use authorisation. That, though, wasn’t the first such authorisation granted by the FDA. As in May this year news emerged that Rutgers University’s Clinical Genomics Laboratory received approval for its COVID-19 laboratory developed test. The developments suggest to us increased acceptance of this mode of testing by the US health regulator. The Yale scientists tell us that the …

Global In-Vitro Colorectal Cancer Screening Tests Industry | Globe Newswire | 8/18/2020

… pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Competitors identified in this market include, among others, Abbott Laboratories, Inc. Clinical Genomics Technologies Pty Ltd. Eiken Chemical Co., Ltd. Read the full report: https://www.reportlinker.com/p05895895/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY In-Vitro Colorectal Cancer Screening Tests Competitor Market Share …

Global In-Vitro Colorectal Cancer Screening Tests Industry | Yahoo News | 8/18/2020

Global In-Vitro Colorectal Cancer Screening Tests Market to Reach $1. 1 Billion by 2027. Amid the COVID-19 crisis, the global market for In-Vitro Colorectal Cancer Screening Tests estimated at US$879. New York, Aug. 18, 2020 (GLOBE NEWSWIRE) – Reportlinker.com announces the release of the report “Global In-Vitro Colorectal Cancer Screening Tests Industry” - https://www.reportlinker.com/p05895895/?utm_source=GNW 1 Million in the year 2020, is projected …

Global In-Vitro Colorectal Cancer Screening Tests Industry | 8/18/2020

Global In-Vitro Colorectal Cancer Screening Tests Market to Reach $1. 1 Billion by 2027. Amid the COVID-19 crisis, the global market for In-Vitro Colorectal Cancer Screening Tests estimated at US$879. New York, Aug. 18, 2020 (GLOBE NEWSWIRE) – Reportlinker.com announces the release of the report “Global In-Vitro Colorectal Cancer Screening Tests Industry” - https://www.reportlinker.com/p05895895/?utm_source=GNW 1 Million in the year 2020, is projected …

Yale-NBA Partnership Results in FDA Approval for COVID-19 SalivaDirect Test | 8/18/2020

… University, with the test having received FDA approval back in April. While the test is an ‘at-home’ test, samples must be specifically mailed to the RUCDR Infinite Biologics, a unit at the Rutgers Clinical Genomics Laboratory in New Jersey. Moreover, the test costs up to $150 for consumers, which can be reduced to $60 or $70 in some circumstances, said Andrew Brooks, an associate professor at Rutgers and chief …

Advanced pathological study for definite diagnosis of mitochondrial cardiomyopathy | BMJ | 8/17/2020

… Metabolism , Chiba Children’s Hospital , Chiba , Japan 3 Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center , Juntendo University School of Medicine Graduate School of Medicine , Bunkyo-ku , Tokyo , Japan 4 Department of Pediatrics & Clinical Genomics , Saitama Medical University Faculty of Medicine , Saitama , Japan 5 Center for Intractable Diseases , Saitama Medical University , Saitama , Japan 6 Department of Surgical Pathology , Hokkaido University Hospital , Sapporo , Japan 7 Department of Research , Charles R …

New comment by eriksjolund in “Ask HN: Who is hiring? (August 2020)” | 8/14/2020

Karolinska Institute Stockholm, Sweden Backend Dev/SysAdmin ONSITE VISA Full-Time (2 year) The Clinical Genomics Stockholm facility https://www.scilifelab.se/facilities/clinical-genomics-stock… provides a dedicated research infrastructure for projects utilising massively parallel / next generation sequencing technologies and performs precision diagnostics for Swedish hospitals. Tech stack: SLURM/MongoDB/MySQL/Postgresql/Containers/Linux/Python/Javascript/Vue Github repo: https://github.com/Clinical-Genomics Required skills: Unix/linux, Bash, Ansible (or […] Jennifer …

NIH

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 - PubMed | National Institutes of Health | 9/26/2020

… NIH, Bethesda, MD, USA. NIAID Clinical Genomics Program, National Institutes of Health, Bethesda, MD, USA. Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Hôpital Saint-Louis, 75010 Paris, France. Laboratory of Genomes & Cell Biology of Disease, INSERM U944, CNRS UMR 7212, Université de Paris, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Paris, France. Sorbonne Université, Inserm, Centre d’immunologie et des maladies infectieuses-Paris (CIMI PARIS), AP-HP …

National Institutes of Health

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 - PubMed | National Institutes of Health | 9/26/2020

Clinical Genomics Program, National Institutes of Health, Bethesda, MD, USA. Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Hôpital Saint-Louis, 75010 Paris, France. Laboratory of Genomes & Cell Biology of Disease, INSERM U944, CNRS UMR 7212, Université de Paris, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Paris, France. Sorbonne Université, Inserm, Centre d’immunologie et des maladies infectieuses-Paris (CIMI PARIS), AP-HP Hôpital Pitié-Salpêtrière, Paris, France …

COVID-19

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 - PubMed | National Institutes of Health | 9/26/2020

… Laouénan 1 , COVID-STORM Clinicians ; COVID Clinicians ; Imagine COVID Group ; French COVID Cohort Study Group ; CoV-Contact Cohort ; Amsterdam UMC Covid-19 ; Biobank ; COVID Human Genetic Effort ; NIAID-USUHS ; TAGC COVID Immunity Group ; Andrew L … Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA. NIAID Clinical Genomics Program, National Institutes of Health, Bethesda, MD, USA. Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Hôpital Saint-Louis, 75010 Paris …

Food and Drug Administration

Sherlock Biosciences Announces Clinical Data from Dartmouth-Hitchcock Health’s Pilot Study of Sherlock™ CRISPR SARS-CoV-2 Kit | Business Wire | 9/2/2020

… results from the pilot study of Sherlock’s CRISPR-based test,” said Wahab Khan, Ph.D., Assistant Director of the Laboratory for Clinical Genomics and Advanced Technology at Dartmouth-Hitchcock. “At a time when COVID-19 clinical … Biosciences recently received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA), is based on the SHERLOCK method, which stands for S pecific H igh sensitivity E nzymatic R eporter un LOCK …

At-Home Testing

After FDA authorizes at-home saliva test for Covid-19, startups begin selling test kits - MedCity News | 5/15/2020

Clinical Genomics Laboratory. Just days after the approval, startups have begun to sell at-home testing kits using Rutgers’ saliva tests. Men’s health startup Vault said it will offer the tests for $150. After patients receive their test kit in the mail, they have a short Zoom call with a healthcare provider to guide them through the collection process before they ship their sample in the mail. Mail-order wellness …

Medicaid

Clinical Genomics Expands Strategic Relationship with Quest Diagnostics and Further Increases Momentum for Innovative First-Line Colorectal Cancer Screening Blood Test | Globe Newswire | 4/30/2020

… the Trident Program – – Further strengthens strategic alliance with Quest Diagnostics focused on the Trident Program for CRC screening – BRIDGEWATER, N.J., Clinical Genomics (“CG” or the “Company”), a provider of advanced cancer diagnostic solutions, including liquid … and Drug Administration (“FDA”) and the Centers for Medicare and Medicaid Services (“CMS”) to finalize clinical study design with the goal of securing U.S. Premarket Approval (“PMA”) and a National Coverage Determination (“NCD”). Strategic Alliance …

Medicare

Clinical Genomics Expands Strategic Relationship with Quest Diagnostics and Further Increases Momentum for Innovative First-Line Colorectal Cancer Screening Blood Test | Globe Newswire | 4/30/2020

… the Trident Program – – Further strengthens strategic alliance with Quest Diagnostics focused on the Trident Program for CRC screening – BRIDGEWATER, N.J., Clinical Genomics (“CG” or the “Company”), a provider of advanced cancer diagnostic solutions, including liquid … U.S. Food and Drug Administration (“FDA”) and the Centers for Medicare and Medicaid Services (“CMS”) to finalize clinical study design with the goal of securing U.S. Premarket Approval (“PMA”) and a National Coverage Determination (“NCD …

Population Health

Genomics in healthcare: How systems are using the data and whether there is a cause for concern | Becker’s Hospital Review | 1/22/2020

population health company Color to scale the health system’s existing Imagenetics program, which has the goal of integrating genetic medicine into preventative care. Sanford will use Color’s next-generation sequencing technology and population health platform while providing insights for clinicians. On Jan. 13, NorthShore University Health System in Evanston, Ill., completed an initiative with Color to bring clinical genomics to 10,000 patients. The partners aim to provide clinically actionable information …

Clinical Research

Genomics in healthcare: How systems are using the data and whether there is a cause for concern | Becker’s Hospital Review | 1/22/2020

… insights for clinicians. On Jan. 13, NorthShore University Health System in Evanston, Ill., completed an initiative with Color to bring clinical genomics to 10,000 patients. The partners aim to provide clinically actionable information to those … escalate to much more severe conditions,” she said. “Or, in clinical research settings, there is a significant discrepancy in the percentage of underserved and/or minority populations tested, which can lead to misleading or dangerous …

Advanced Primary Care

NorthShore Provides Clinical Genomic Testing to 10K Patients | HealthIT Analytics | 1/22/2020

… and Color have delivered actionable clinical genomic results to 10,000 patients through their DNA-10K program, which aims to integrate clinical genomics and routine primary care. The partnership incorporates clinical genomic results with patients’ EHR … Cuts ED Visits by 42% “We’ve built a model of Advanced Primary Care that is transforming the delivery of healthcare,” said J.P. Gallagher, President and Chief Executive Officer of NorthShore. “We’ve seen firsthand that genetic …

Medical Research

Research Officer - Eating Disorders | Nature | 12/2/2019

Sydney, Darlinghurst, Australia Posted about 8 hours ago Expires on January 31, 2020 The Garvan Institute of Medical Research (Garvan) is one of Australia’s leading medical research institutes, with over 600 scientists, students and support … Aging, and Genomics, and two Centres: the Kinghorn Centre for Clinical Genomics and the Garvan-Weizmann Centre for Cellular Genomics. The Opportunity We are currently seeking a talented and driven Research Officer to join the …

Precision Medicine

Experts Take a Deep Dive into Precision Medicine | 11/27/2019

Experts Take a Deep Dive into Precision Medicine Genomic medicine leaders gathered at the 4th annual AGBT precision health meeting By Source: Vijay kumar / DigitalVision Vectors / Getty Images Share Held in early September in La … in detail in 2015 in The Atlantic) in which her clinical genomics lab detected a PTPN11 variant in a fetus with increased nuchal translucency on the ultrasound. The variant had been reported as pathogenic previously …

Clinical Diagnostics

Artificial intelligence in clinical and genomic diagnostics | 11/19/2019

… clinical diagnostics, AI-based computer vision approaches are poised to revolutionize image-based diagnostics, while other AI subtypes have begun to show similar promise in various diagnostic modalities. In some areas, such as clinical genomics, a specific type of AI algorithm known as deep learning is used to process large and complex genomic datasets. In this review, we first summarize the main classes of problems that AI systems are well …

Molecular Diagnostics

Startup PHIX Genomics Aims to Introduce Clinical Molecular Diagnostics to Philippines in 2020 | 11/19/2019

Justin Petrone Premium NEW YORK – PHIX Genomics is a new clinical genomics diagnostics company that aims to be operational in the Philippines by the second quarter of next year, serving the country with a menu of tests that will include cancer profiling, pharmacogenomic, inherited disease screening, and other assays. Clinical genomics is just one business area for PHIX, which also intends to sell genomic tools and introduce a variety of …

Cancer Diagnostics

RTI International Announces Follow-On Investment in Precision Medicine Company PierianDX | PR Newswire | 11/14/2019

clinical genomics as a standard of care and empowers the world’s most advanced molecular diagnostic labs. Founded in 2014 out of Washington University in St. Louis , PierianDx is focused on advancing cancer diagnostics and making targeted therapeutics more accessible to healthcare systems, laboratories and patients worldwide. “We are impressed by the progress PierianDx is making in accelerating genomic testing across global markets,” said Matt Jenkins, vice president and head of …

Biotech

Global Genetic Testing Market to 2024: CGES Testing - A Brave New World | PR Newswire | 11/14/2019

… Biotechnologies Admera Health, LLC Agena Bioscience, Inc Agilent Akonni Biosystems Ancestry.com LLC Anchor Dx ArcherDx, Inc ARUP Laboratories Asuragen Baylor Miraca Genetics Laboratories Beckman Coulter , Inc Becton, Dickinson and Company BGI Genomics Co. Ltd Bioarray Genetics Biocept, Inc Biodesix Inc BioFluidica BioGenex Biolidics Ltd bioMrieux Diagnostics Bioneer Corporation Bio-Rad Laboratories, Inc Bio-Techne Cancer Genetics Caris Molecular Diagnostics CellMax Life Centogene Chronix Biomedical Circulogene Clinical Genomics Color Genomics Complete …

Diagnostic Tests

Immuno-Oncology Diagnostics: The Race for Biomarkers Market to 2024 | Markets Insider | Business Insider | 11/14/2019

… Hematogenix Launches FDA Approved Immuno-oncology Test for Triple-Negative Breast Cancer Icon Acquires MolecularMD Guardant Health to Develop Companion Diagnostic Tests for AstraZeneca Tumor Mutational Burden as Predictor of Immunotherapy Success Foundation Medicine and … CellMax Life Charles River Laboratories Chronix Biomedical Circulogene Clearbridge BioMedics Clinical Genomics Cynvenio Cytolumina Technologies Corp. CytoTrack Dako (Agilent) Diagnologix LLC Epic Sciences Exosome Diagnostics Fluidigm Corp Fluxion Biosciences Foundation Medicine Freenome Genomic Health GenomOncology …

Personal Genome Diagnostics

Immuno-Oncology Diagnostics: The Race for Biomarkers Market to 2024 | Markets Insider | Business Insider | 11/14/2019

… Immuno-Oncology Panel 10x Genomics Acquires Epinomics, To Launch ATAC-Seq Product Qiagen, Freenome Partner to Improve Companion Diagnostic Development Personal Genome Diagnostics to Develop Companion Diagnostic for Five Prime Thermo Fisher Expands Oncomine Immuno … CellMax Life Charles River Laboratories Chronix Biomedical Circulogene Clearbridge BioMedics Clinical Genomics Cynvenio Cytolumina Technologies Corp. CytoTrack Dako (Agilent) Diagnologix LLC Epic Sciences Exosome Diagnostics Fluidigm Corp Fluxion Biosciences Foundation Medicine Freenome Genomic Health GenomOncology …

Clinical Decision Support

Congenica Appoints Dr. Heiner Dreismann as Non-Executive Director | PR Newswire | 11/5/2019

clinical genomics and precision medicine.” About Congenica Congenica is a digital health company enabling genomic medicine with the world’s leading clinical decision support platform for the interpretation of complex genomic data. Congenica integrates genetic data into healthcare, empowering clinicians to provide life-changing answers that transform the lives of individuals, patients and their families. Born out of pioneering research from the Wellcome Sanger Institute and the NHS, Congenica is headquartered …

Laboratory Information Systems

Fabric Genomics and XIFIN Partner to Expand Access to Clinical Genomics | Business Wire | 9/5/2019

… have slowed mainstream adoption of these breakthrough technologies. Today, Fabric Genomics, a global leader in clinical interpretation of genomic data, announced a distribution agreement with XIFIN, the leader in revenue cycle management and laboratory information systems, that will increase mainstream access to cutting-edge genomic technologies and testing. As a result of this partnership, Fabric Genomics’ market-leading AI-driven genomic interpretation platform, Fabric Enterprise, will be integrated with XIFIN …

Revenue Cycle Management

Fabric Genomics and XIFIN Partner to Expand Access to Clinical Genomics | Business Wire | 9/5/2019

… clinically meaningful and routinized have slowed mainstream adoption of these breakthrough technologies. Today, Fabric Genomics, a global leader in clinical interpretation of genomic data, announced a distribution agreement with XIFIN, the leader in revenue cycle management and laboratory information systems, that will increase mainstream access to cutting-edge genomic technologies and testing. As a result of this partnership, Fabric Genomics’ market-leading AI-driven genomic interpretation platform, Fabric Enterprise, will …

ACA

SeraCare Announces Industry’s First CNV-Specific Reference Material for Gene Amplifications in | PR Newswire | 2/13/2018

MILFORD, Mass. , Feb 13, 2018 /PRNewswire/ – SeraCare Life Sciences , a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, is expanding what is already the most comprehensive suite of clinical genomics development, validation, and QC tools with the launch of the Seraseq TM Breast CNV and Seraseq™ Lung and Brain CNV Mix . Reference materials that analyze for CNVs allow for a complete and comprehensive variant assessment …

ACO

Dartmouth and University of Southern California Studies Highlight ChromaCode HDPCR™ as Compelling Multiplexing Alternative | PR Newswire | 11/21/2017

Dartmouth and University of Southern California Studies Highlight ChromaCode HDPCR™ as Compelling Multiplexing Alternative · Two medical institutions present first HDPCR™ data during AMP 2017 Annual Meeting.· Demonstrate HDPCR offers a novel, cost-effective and high … applications,” said Greg Tsongalis , PhD, HCLD, CCC, Director, Laboratory for Clinical Genomics and Advanced Technology, Dartmouth-Hitchcock Medical Center. The USC study evaluated the performance of the HDPCR respiratory assay (IUO) for the detection of …

Patient Management

SeraCare Announces Industry’s First Comprehensive NGS Reference Material for Hematologic Malignancies | PR Newswire | 11/8/2017

… partner to global in vitro diagnostics manufacturers and clinical laboratories, is expanding what is already the most comprehensive suite of clinical genomics development, validation, and QC tools with the launch of the Seraseq TM Myeloid … the ultimate end-goal of driving accurate diagnosis and effective patient management.” “With the release of the industry’s first comprehensive NGS reference materials for myeloid cancers, we expand our commitment and leadership in the clinical …

Medical Diagnostics

Europe Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay and | PR Newswire | 10/25/2017

… Biomedical Diagnostics/Theradiag - bioMerieux - Bio-Rad - CellSearch - Cepheid - Correlogic Systems/Vermillion - Decode Genetics - Diadexus - Diagnocure - DiaSorin - Eiken Chemical - Elitech Group - Enterix/Clinical Genomics - Enzo Biochem - Epigenomics - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic/Gen-Probe - Kreatech/Leica - Kyowa Medex - Mackay Life Sciences - Myriad Genetics - OncoLab - Ortho-Clinical Diagnostics - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen - Quest Diagnostics - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics and Therapeutics - Thermo Fisher …

Adaptive Biotechnologies

Global Genetic Testing Industry Outlook to 2023 with Market Shares by Key Players | PR Newswire | 8/28/2020

Adaptive Biotechnologies Admera Health, LLC Agena Bioscience, Inc. Agilent Akonni Biosystems Ancestry.com LLC Anchor Dx ArcherDx, Inc. ARUP Laboratories Asuragen Beckman Coulter , Inc. Becton, Dickinson and Company BGI Genomics Co. Ltd. Bioarray Genetics Biocept, Inc. Biodesix Inc. BioFluidica BioGenex Biolidics Ltd. bioMrieux Diagnostics Bioneer Corporation Bio-Rad Laboratories, Inc. Bio-Techne Cancer Genetics Caris Molecular Diagnostics CellMax Life Centogene Cepheid (now Danaher) Chronix Biomedical Circulogene Clinical Genomics Complete Genomics, Inc …

Quest Diagnostics

Alternative sample types could boost COVID-19 testing | Modern Healthcare | 4/30/2020

… to use them in the field “very soon.” Also, on April 10, the Food and Drug Administration gave the Rutgers Clinical Genomics Laboratory approval for the first test to include saliva as a specimen type … use with the SARS-CoV-2 RNA tests offered through Quest Diagnostics at this time,” said a spokesperson for Quest. KorvaLabs, an anti-doping testing lab, and Curative, meanwhile, received FDA expedited approval for a …

Thermo Fisher

FDA grants emergency use authorization to saliva-based Covid-19 test - MedCity News | 4/13/2020

Clinical Genomics Laboratory. The test also uses Thermo Fisher Scientific’s TaqPath SARS-CoV-2 detection system and nucleic acid extraction technology from Perkin Elmer. Rutgers noted in its own announcement that RUCDR developed the test in partnership with Spectrum and Accurate Diagnostic Labs, and that the test would allow for broader population screening than nose and throat swabs. “Using saliva to test for Covid-19 overcomes many of the challenges …

Thermo Fisher Scientific

FDA grants emergency use authorization to saliva-based Covid-19 test - MedCity News | 4/13/2020

Clinical Genomics Laboratory. The test also uses Thermo Fisher Scientific’s TaqPath SARS-CoV-2 detection system and nucleic acid extraction technology from Perkin Elmer. Rutgers noted in its own announcement that RUCDR developed the test in partnership with Spectrum and Accurate Diagnostic Labs, and that the test would allow for broader population screening than nose and throat swabs. “Using saliva to test for Covid-19 overcomes many of the challenges …

Biocept

Visiongain Report Offers Transformative Insights on the $4.9bn Liquid Biopsy Market | PR Newswire | 1/13/2020

… Turkey • Venezuela • Saudi Arabia • Republic of South Africa • Rest of LAMEA • Profiles of the selected leading companies: • Abbott • Beckman Coulter • Biocept, Inc. • Bio-Rad Laboratories • Biotime • Caris Lifesciences • F. Hoffman- La Roche • Guardant Health, Inc … Catalyst Pharmaceuticals CellMax Life Cerba HealthCare Cirina, Ltd. Clearbridge BioMedics Clinical Genomics Clovis Oncology CORE Diagnostics Daiichi Sankyo Exact Sciences Corp. F. Hoffmann-La Roche AG Fondazione Luigi Maria Monti - Istituto Dermopatico dell’ Immacolata Hospital …

Myriad Genetics

Visiongain Report Offers Transformative Insights on the $4.9bn Liquid Biopsy Market | PR Newswire | 1/13/2020

… Rad Laboratories • Biotime • Caris Lifesciences • F. Hoffman- La Roche • Guardant Health, Inc. • Illumina, Inc. • MDxHealth SA • Menarini Silicon Biosystems, Inc. • Myriad Genetics, Inc. • OPKO Health, Inc. • Qiagen N.V. • Sysmex Inostics • Trovagene, Inc. • This report discusses … Catalyst Pharmaceuticals CellMax Life Cerba HealthCare Cirina, Ltd. Clearbridge BioMedics Clinical Genomics Clovis Oncology CORE Diagnostics Daiichi Sankyo Exact Sciences Corp. F. Hoffmann-La Roche AG Fondazione Luigi Maria Monti - Istituto Dermopatico dell’ Immacolata Hospital …

PierianDx

Intermountain Healthcare Selects PierianDx Clinical Genomics Solution | Business Wire | 12/11/2019

ST. LOUIS–(BUSINESS WIRE)–Dec 11, 2019– PierianDx, the leading clinical genomics informatics company, today announced that Intermountain Healthcare has selected the PierianDx Clinical Genomics Workstation to advance their precision medicine program, Intermountain Precision Genomics. Intermountain Healthcare will leverage PierianDx for next-generation sequencing (NGS) variant analysis, classification, and reporting services to assist in the identification of targeted therapies and potential clinical trial opportunities for cancer patients. PierianDx provides a …

Siemens

Global Genetic Testing Market to 2024: CGES Testing - A Brave New World | PR Newswire | 11/14/2019

… Diagnostics Bioneer Corporation Bio-Rad Laboratories, Inc Bio-Techne Cancer Genetics Caris Molecular Diagnostics CellMax Life Centogene Chronix Biomedical Circulogene Clinical Genomics Color Genomics Complete Genomics, Inc. - A BGI Company Cynvenio Dante Labs Datar Cancer … Gmbh Quantumdx Regeneron Roche Molecular Diagnostics Roswell Biotechnologies Seegene Sequencing.com Siemens Healthineers simfo GmbH Singlera Genomics Inc SkylineDx Stratos Genomics Sure Genomics, Inc Sysmex Sysmex Inostics Tempus Labs, Inc Thermo Fisher Scientific Inc Veritas Genetics …

Freenome

Global Genetic Testing Market to 2024: CGES Testing - A Brave New World | PR Newswire | 11/14/2019

Clinical Genomics Color Genomics Complete Genomics, Inc. - A BGI Company Cynvenio Dante Labs Datar Cancer Genetics Limited Diasorin S.p.A Epic Sciences Epigenomics AG Eurofins Scientific Excellerate Bioscience Exosome Diagnostics Fabric Genomics Fluidigm Corp Foundation Medicine Freenome FUJIFILM Wako Diagnostics Fujirebio GE Global Research GE Healthcare Life Sciences Gene by Gene, Ltd Genedrive GeneFirst Ltd Genetron Health ( Beijing ) Co., Ltd Genewiz Genomic Health Genomics England Genomics Personalized Health (GPH) GenomOncology Genzyme …

Qiagen

Global Genetic Testing Market to 2024: CGES Testing - A Brave New World | PR Newswire | 11/14/2019

… Canine Consumer Genomics Firm Embark Veterinary Raises $10M Yourgene Health to Acquire Elucigene Helix, AdventHealth Partner on Genetic Screening Study Qiagen, NeuMoDx Ink Partnership, Merger Agreement Prenetics Acquires DNAFit for $10M Myriad Genetics to Acquire … Genetics Caris Molecular Diagnostics CellMax Life Centogene Chronix Biomedical Circulogene Clinical Genomics Color Genomics Complete Genomics, Inc. - A BGI Company Cynvenio Dante Labs Datar Cancer Genetics Limited Diasorin S.p.A Epic Sciences Epigenomics AG Eurofins Scientific …

Siemens Healthineers

Global Genetic Testing Market to 2024: CGES Testing - A Brave New World | PR Newswire | 11/14/2019

… Diagnostics Bioneer Corporation Bio-Rad Laboratories, Inc Bio-Techne Cancer Genetics Caris Molecular Diagnostics CellMax Life Centogene Chronix Biomedical Circulogene Clinical Genomics Color Genomics Complete Genomics, Inc. - A BGI Company Cynvenio Dante Labs Datar Cancer … Gmbh Quantumdx Regeneron Roche Molecular Diagnostics Roswell Biotechnologies Seegene Sequencing.com Siemens Healthineers simfo GmbH Singlera Genomics Inc SkylineDx Stratos Genomics Sure Genomics, Inc Sysmex Sysmex Inostics Tempus Labs, Inc Thermo Fisher Scientific Inc Veritas Genetics …

Health Catalyst

RTI International Announces Follow-On Investment in Precision Medicine Company PierianDX | PR Newswire | 11/14/2019

… 27 million Series B funding round, which includes new investors ATW Partners and SJF Ventures along with existing investors of Health Catalyst Capital, Inova Health Systems and ARUP Laboratories. “Advancements in the ability to harness … PierianDx provides a SaaS platform that enables the practice of clinical genomics as a standard of care and empowers the world’s most advanced molecular diagnostic labs. Founded in 2014 out of Washington University in St …

Genomic Health

Immuno-Oncology Diagnostics: The Race for Biomarkers Market to 2024 | Markets Insider | Business Insider | 11/14/2019

Clinical Genomics Cynvenio Cytolumina Technologies Corp. CytoTrack Dako (Agilent) Diagnologix LLC Epic Sciences Exosome Diagnostics Fluidigm Corp Fluxion Biosciences Foundation Medicine Freenome Genomic Health GenomOncology GRAIL Guardant Health HalioDx Horizon Discovery HTG Molecular Diagnostics iCellate Illumina Incell Dx Inivata Integrated Diagnostics Invivoscribe Leica Biosystems Luminex MDx Health Merck & Co., Inc MIODx Molecular MD MRM Proteomics Inc Myriad Genetics/Myriad RBM Nanostring Natera Neogenomics New Oncology Oncocyte Ortho Clinical Diagnostics Perkin …

Guardant Health

Immuno-Oncology Diagnostics: The Race for Biomarkers Market to 2024 | Markets Insider | Business Insider | 11/14/2019

… Companion Diagnostics for Cancer Therapies Hematogenix Launches FDA Approved Immuno-oncology Test for Triple-Negative Breast Cancer Icon Acquires MolecularMD Guardant Health to Develop Companion Diagnostic Tests for AstraZeneca Tumor Mutational Burden as Predictor of … CellMax Life Charles River Laboratories Chronix Biomedical Circulogene Clearbridge BioMedics Clinical Genomics Cynvenio Cytolumina Technologies Corp. CytoTrack Dako (Agilent) Diagnologix LLC Epic Sciences Exosome Diagnostics Fluidigm Corp Fluxion Biosciences Foundation Medicine Freenome Genomic Health GenomOncology …

Abbott Laboratories

Colorectal Cancer Market expected to reach $13.01 billion by 2026 growing at a CAGR of 3.9% | Abbott Laboratories, Amgen Inc., Clinical Genomics, EDP Biotech, Epigenomics AG, Hoffmann-La Roche AG, Novigenix SA | 11/11/2019

… Abbott Laboratories, Amgen Inc., Clinical Genomics, EDP Biotech, Epigenomics AG, Hoffmann-La Roche AG, Novigenix SA, Quest Diagnostics, Sanofi SA , Siemens Healthineers, VolitionRX Get sample copy of “Colorectal Cancer Market” at: https://www.premiummarketinsights.com/sample/SMRC00019566 The “Global Colorectal Cancer Market” is a specialized and in-depth study of the automotive and transportation industry with a special focus on the global market trend analysis. The report aims to provide an overview …

Illumina

Lexent Bio Enters Partnership with Illumina to Develop an In Vitro Diagnostic Kit | PR Newswire | 11/8/2019

… PRNewswire/ – Lexent Bio, Inc., a precision oncology company developing novel liquid biopsy systems, today announced a non-exclusive partnership with Illumina, Inc. (NASDAQ: ILMN ) to develop an in-vitro diagnostic (IVD) kit for Lexent’s future … content to customers and patients represent an exciting opportunity in clinical genomics,” said Dr. Phil Febbo , Chief Medical Officer of Illumina. “We are committed to accelerating the menu of clinical tests available on our diagnostic …

2bPrecise

Ochsner Health System teaming up with Color on population health pilot | FierceHealthcare | 10/19/2019

… care. Calling it the first “fully-digital population health program,” Ochsner will work with the health technology company to incorporate clinical genomics into primary care with a focus on impacting patients’ health further downstream. Developed … Clinic and SurgiCenter in Tennessee are working with technology company 2bPrecise, a subsidiary of health IT company Allscripts, to integrate pharmacogenomic test results at the point of care. In August, Color was awarded a $4.6 …

XIFIN

Fabric Genomics and XIFIN Partner to Expand Access to Clinical Genomics | Business Wire | 9/5/2019

… to make genomic data clinically meaningful and routinized have slowed mainstream adoption of these breakthrough technologies. Today, Fabric Genomics, a global leader in clinical interpretation of genomic data, announced a distribution agreement with XIFIN, the leader in revenue cycle management and laboratory information systems, that will increase mainstream access to cutting-edge genomic technologies and testing. As a result of this partnership, Fabric Genomics’ market-leading AI-driven genomic interpretation …

Exact Sciences

Europe Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay and | PR Newswire | 10/25/2017

Clinical Genomics - Enzo Biochem - Epigenomics - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic/Gen-Probe - Kreatech/Leica - Kyowa Medex - Mackay Life Sciences - Myriad Genetics - OncoLab - Ortho-Clinical Diagnostics - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen - Quest Diagnostics - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics and Therapeutics - Thermo Fisher - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zilla List of Tables France , Total Tumor Marker Sales by Major Supplier France , AFP …

SJF Ventures

Business Briefs: Dale Carnegie of India Educates 500 Underprivileged Children | Business | indiawest.com | 11/30/2019

clinical genomics informatics company, has closed a $27 million Series B funding round led by ATW Partners and SJF Ventures. PierianDx provides a SaaS platform that enables the practice of clinical genomics as a standard of care and empowers the world’s most advanced molecular diagnostic labs. Founded in 2014 out of Washington University in St. Louis, PierianDx is focused on advancing cancer diagnostics and making targeted therapeutics more accessible to …

RTI International Announces Follow-On Investment in Precision Medicine Company PierianDX | PR Newswire | 11/14/2019

… The transaction includes RTI’s participation in a $27 million Series B funding round, which includes new investors ATW Partners and SJF Ventures along with existing investors of Health Catalyst Capital, Inova Health Systems and ARUP … PierianDx provides a SaaS platform that enables the practice of clinical genomics as a standard of care and empowers the world’s most advanced molecular diagnostic labs. Founded in 2014 out of Washington University in St …

Health Catalyst Capital

RTI International Announces Follow-On Investment in Precision Medicine Company PierianDX | PR Newswire | 11/14/2019

… 27 million Series B funding round, which includes new investors ATW Partners and SJF Ventures along with existing investors of Health Catalyst Capital, Inova Health Systems and ARUP Laboratories. “Advancements in the ability to harness … PierianDx provides a SaaS platform that enables the practice of clinical genomics as a standard of care and empowers the world’s most advanced molecular diagnostic labs. Founded in 2014 out of Washington University in St …

PierianDx Closes Series B Financing Round to Facilitate the Democratization of Clinical Next-Generation Sequencing | Malvern Daily Record | 10/28/2019

PierianDx, the leading clinical genomics informatics company, today announced that it has closed a $27 million Series B funding round led by ATW Partners and SJF Ventures that also includes existing investors Health Catalyst Capital, Inova Health Systems, RTI International, and ARUP Laboratories. PierianDx provides a SaaS platform that enables the practice of clinical genomics as a standard of care and empowers the world’s most advanced molecular diagnostic labs. Founded …

Dartmouth-Hitchcock Medical Center

Sherlock Biosciences Announces Clinical Data from Dartmouth-Hitchcock Health’s Pilot Study of Sherlock™ CRISPR SARS-CoV-2 Kit | Business Wire | 9/2/2020

… today reported data from a 20 clinical sample pilot study conducted by Gregory J. Tsongalis, Ph.D., and his team at Dartmouth-Hitchcock Medical Center in Lebanon, NH. The study evaluated the accuracy and performance of … said Wahab Khan, Ph.D., Assistant Director of the Laboratory for Clinical Genomics and Advanced Technology at Dartmouth-Hitchcock. “At a time when COVID-19 clinical diagnosis is in high demand – and often with limited resources …

LexaGene Places a Pre-Commercial Instrument for COVID-19 Testing in a Major Hospital Laboratory | Globe Newswire | 5/28/2020

BEVERLY, Mass., May 28, 2020 (GLOBE NEWSWIRE) – LexaGene Holdings, Inc. ( TSX-V: LXG ; OTCQB: LXXGF ) (the “ Company ”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, is pleased to announce the placing of a pre-commercial instrument that tests for COVID-19 and other respiratory pathogens at the Dartmouth-Hitchcock Medical Center (DHMC) in their Laboratory for Clinical Genomics and Advanced Technology (CGAT) in …

NYC Health and Hospitals

Alternative sample types could boost COVID-19 testing | Modern Healthcare | 4/30/2020

… the past few weeks and are increasingly being implemented. For example, New York City Mayor Bill de Blasio said that NYC Health and Hospitals community testing sites will start letting patients collect their own nasal … April 10, the Food and Drug Administration gave the Rutgers Clinical Genomics Laboratory approval for the first test to include saliva as a specimen type. As of Wednesday, the lab, housed at RUCDR Infinite Biologics …

Alternative sample types could boost COVID-19 testing | Modern Healthcare | 4/30/2020

… the past few weeks and are increasingly being implemented. For example, New York City Mayor Bill de Blasio said that NYC Health and Hospitals community testing sites will start letting patients collect their own nasal … April 10, the Food and Drug Administration gave the Rutgers Clinical Genomics Laboratory approval for the first test to include saliva as a specimen type. As of Wednesday, the lab, housed at RUCDR Infinite Biologics …

NorthShore University HealthSystem

Genomics in healthcare: How systems are using the data and whether there is a cause for concern | Becker’s Hospital Review | 1/22/2020

… effects is alluring, there are also potential risks if the information isn’t managed appropriately. Genomic partnerships at Mayo, Sanford and NorthShore University HealthSystem The start of 2020 has also heralded three major genomics partnerships. On … in Evanston, Ill., completed an initiative with Color to bring clinical genomics to 10,000 patients. The partners aim to provide clinically actionable information to those individuals, and throughout this year will upgrade their genomic testing …

NorthShore Provides Clinical Genomic Testing to 10K Patients | HealthIT Analytics | 1/22/2020

NorthShore University HealthSystem and Color have completed the largest US genomics program to date, providing genomic results to 10,000 participants. Source: Getty Images By January 22, 2020 - NorthShore University HealthSystem and Color have delivered actionable clinical genomic results to 10,000 patients through their DNA-10K program, which aims to integrate clinical genomics and routine primary care. The partnership incorporates clinical genomic results with patients’ EHR data , where real-time alerts …

Ochsner Health System

Health technology company Color scores $75M funding round to scale its infrastructure | FierceHealthcare | 1/16/2020

Ochsner Health System on a first-of-its-kind, fully digital population health pilot program that integrates clinical genomics into standard care. The company is expanding its partnerships with healthcare systems looking to integrate genetic testing into the primary care setting. This week, the company announced that it had met its goal of enrolling 10,000 patients into the DNA-10K program a year after launching it with NorthShore University Health …

Ochsner Health System, Color team on population health pilot program | 10/21/2019

Ochsner Health System and genetic testing vendor Color are collaborating on what they contend is a “first of its kind, fully digital” population health pilot integrating clinical genomics into standard care. “The partnership leverages Color’s unique combination of medical grade genetics, clinical services and patient engagement with Louisiana-based Ochsner’s approach to making individualized patient-level insights actionable and integrating them into routine patient care at scale,” according to the …

Stanford Medicine

Doctors, Students Expect and Embrace Many Tech Advances: Survey | Medscape | 1/10/2020

… are preparing to integrate health data of various kinds into the clinical setting, according to a new national survey by Stanford Medicine. However, the survey shows, the majority of respondents felt ill-prepared for the … the students were population health management (36%), genetic counseling (30%), clinical genomics (25%), coding and programming (23%), and artificial intelligence (13%). Physicians had different priorities. They were most interested in learning about genetic counseling (38 …

Are the History and Physical Coming to an End? | Medscape | 9/9/2019

… relevance of obtaining a history or performing a physical has been questioned in the past, particularly with the emergence of clinical genomics and increasingly automated laboratory testing. In 1975, the British Medical Journal published a … during a physician-patient interaction is quantifiable.” Stanford Medical School’s Stanford Medicine 25 program is one of the leading programs intent on fostering bedside medicine. Through various in-person and online courses, it trains young …

Mayo Clinic

Hereditary Polyposis Syndromes. - PubMed - NCBI | 11/18/2019

… Clinical Genomics, Mayo Clinic, Phoenix, AZ, USA. 4 Division of Gastroenterology, University of California San Francisco, 505 Parnassus Ave, Room S357, San Francisco, CA, 941943, USA. [email protected] Abstract PURPOSE OF REVIEW: Colorectal cancer (CRC) is the third most common cancer in the USA and inherited cancer syndromes are responsible for approximately 3-5% of all CRCs. Genetic testing costs have plummeted in recent years; however, awareness and referral of high …

Bionano Genomics Reports Third Quarter 2019 Financial Results and Provides Business Update - GuruFocus.com | 11/7/2019

… Announced Saphyr has been adopted by leading organizations, including PerkinElmer Genomics and the University of Iowa, for use in their clinical genomics laboratories, replacing traditional methods for clinical testing. Additionally, the Company announced that PerkinElmer … MD Anderson Cancer Center of the University of Texas, the Mayo Clinic, the University of Washington, Penn State University, Augusta University and the PathGroup. In another study, Dr. Kanagal-Shamanna presented results from the analysis …

Inova Health System

RTI International Announces Follow-On Investment in Precision Medicine Company PierianDX | PR Newswire | 11/14/2019

… B funding round, which includes new investors ATW Partners and SJF Ventures along with existing investors of Health Catalyst Capital, Inova Health Systems and ARUP Laboratories. “Advancements in the ability to harness knowledge from genomics … PierianDx provides a SaaS platform that enables the practice of clinical genomics as a standard of care and empowers the world’s most advanced molecular diagnostic labs. Founded in 2014 out of Washington University in St …

PierianDx Closes Series B Financing Round to Facilitate the Democratization of Clinical Next-Generation Sequencing | Malvern Daily Record | 10/28/2019

PierianDx, the leading clinical genomics informatics company, today announced that it has closed a $27 million Series B funding round led by ATW Partners and SJF Ventures that also includes existing investors Health Catalyst Capital, Inova Health Systems, RTI International, and ARUP Laboratories. PierianDx provides a SaaS platform that enables the practice of clinical genomics as a standard of care and empowers the world’s most advanced molecular diagnostic labs. Founded …

Andrew Brooks

FDA authorizes first at-home saliva test kit for Covid-19 - MedCity News | 5/11/2020

… using saliva, the agency said Friday. Rutgers University said Friday that the FDA had given the EUA to the Rutgers Clinical Genomics Laboratory’s TaqPath SARS-CoV-2 Assay, developed by the university’s RUCDR Infinite Biologics … day in places other than a healthcare setting,” RUCDR COO Andrew Brooks said in a statement. “This will enable testing for people who do not have the means to get to a collection center and …

FDA authorizes first at-home saliva test kit for Covid-19 - MedCity News | 5/11/2020

… using saliva, the agency said Friday. Rutgers University said Friday that the FDA had given the EUA to the Rutgers Clinical Genomics Laboratory’s TaqPath SARS-CoV-2 Assay, developed by the university’s RUCDR Infinite Biologics … day in places other than a healthcare setting,” RUCDR COO Andrew Brooks said in a statement. “This will enable testing for people who do not have the means to get to a collection center and …

Bill de Blasio

Alternative sample types could boost COVID-19 testing | Modern Healthcare | 4/30/2020

… But alternatives have emerged over the past few weeks and are increasingly being implemented. For example, New York City Mayor Bill de Blasio said that NYC Health and Hospitals community testing sites will start letting … April 10, the Food and Drug Administration gave the Rutgers Clinical Genomics Laboratory approval for the first test to include saliva as a specimen type. As of Wednesday, the lab, housed at RUCDR Infinite Biologics …

Alternative sample types could boost COVID-19 testing | Modern Healthcare | 4/30/2020

… But alternatives have emerged over the past few weeks and are increasingly being implemented. For example, New York City Mayor Bill de Blasio said that NYC Health and Hospitals community testing sites will start letting … April 10, the Food and Drug Administration gave the Rutgers Clinical Genomics Laboratory approval for the first test to include saliva as a specimen type. As of Wednesday, the lab, housed at RUCDR Infinite Biologics …

New York, New York

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 - PubMed | National Institutes of Health | 9/26/2020

… Jean-Laurent Casanova 2 Affiliations 1 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA. Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163 … Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA. NIAID Clinical Genomics Program, National Institutes of Health, Bethesda, MD, USA. Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Hôpital Saint-Louis, 75010 Paris …

Global In-Vitro Colorectal Cancer Screening Tests Industry | Yahoo News | 8/18/2020

… 2027. Amid the COVID-19 crisis, the global market for In-Vitro Colorectal Cancer Screening Tests estimated at US$879. New York, Aug. 18, 2020 (GLOBE NEWSWIRE) – Reportlinker.com announces the release of the report “Global … Story continues Abbott Laboratories, Inc. Alere, Inc. Beckman Coulter, Inc. Clinical Genomics Technologies Pty Ltd. Eiken Chemical Co., Ltd. Epigenomics AG Exact Sciences Corporation Hemosure, Inc. Novigenix SA Quidel Corporation Sysmex Corporation Read the full …

York, Pennsylvania

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 - PubMed | National Institutes of Health | 9/26/2020

… Laurent Casanova 2 Affiliations 1 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA. Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker … Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA. NIAID Clinical Genomics Program, National Institutes of Health, Bethesda, MD, USA. Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Hôpital Saint-Louis, 75010 Paris …

Global In-Vitro Colorectal Cancer Screening Tests Industry | Yahoo News | 8/18/2020

… Amid the COVID-19 crisis, the global market for In-Vitro Colorectal Cancer Screening Tests estimated at US$879. New York, Aug. 18, 2020 (GLOBE NEWSWIRE) – Reportlinker.com announces the release of the report “Global In … Story continues Abbott Laboratories, Inc. Alere, Inc. Beckman Coulter, Inc. Clinical Genomics Technologies Pty Ltd. Eiken Chemical Co., Ltd. Epigenomics AG Exact Sciences Corporation Hemosure, Inc. Novigenix SA Quidel Corporation Sysmex Corporation Read the full …

State of New York

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 - PubMed | National Institutes of Health | 9/26/2020

… Jean-Laurent Casanova 2 Affiliations 1 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA. Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163 … Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA. NIAID Clinical Genomics Program, National Institutes of Health, Bethesda, MD, USA. Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Hôpital Saint-Louis, 75010 Paris …

Global In-Vitro Colorectal Cancer Screening Tests Industry | Yahoo News | 8/18/2020

… 2027. Amid the COVID-19 crisis, the global market for In-Vitro Colorectal Cancer Screening Tests estimated at US$879. New York, Aug. 18, 2020 (GLOBE NEWSWIRE) – Reportlinker.com announces the release of the report “Global … Story continues Abbott Laboratories, Inc. Alere, Inc. Beckman Coulter, Inc. Clinical Genomics Technologies Pty Ltd. Eiken Chemical Co., Ltd. Epigenomics AG Exact Sciences Corporation Hemosure, Inc. Novigenix SA Quidel Corporation Sysmex Corporation Read the full …